XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Cash flows from operating activities    
Net loss $ (30,609) $ (9,823)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization 5,394 4,166
Amortization of right-of-use asset 378 0
Amortization of debt issuance costs 56 634
Amortization of prior hedge effectiveness 0 1,328
Impairment of other equity securities 170 0
Stock-based compensation 21,865 3,786
Deferred income taxes 2,791 (3,259)
Change in fair value of financial guarantee 0 (75)
Change in fair value of derivative instruments 0 28
Unrealized foreign exchange loss (gain) 1,379 (107)
Other 0 4
Changes in operating assets and liabilities:    
Accounts receivable (2,150) (2,156)
Prepaid expenses and other current assets (6,706) (1,344)
Other assets (811) (215)
Accounts payable (117) 6,026
Accrued expenses and other liabilities 5,675 14,062
Operating lease liabilities (770) 0
Income tax payable 7 (1)
Deferred revenue 17,185 18,361
Net cash provided by operating activities 13,737 31,415
Cash flows from investing activities    
Proceeds from acquisition working capital adjustment 304 0
Purchase of property and equipment (4,911) (2,911)
Net cash used in investing activities (4,607) (2,911)
Cash flows from financing activities    
Repayment of capital lease obligations (4) (8)
Repayment of 2018 Term Loan 0 (1,337)
Repayment of hybrid debt 0 (546)
Repurchase of common stock (1,094) 0
Deferred offering costs 0 (8)
Payment of special dividends 0 (25)
Repurchases of common stock for tax withholding obligations (11) (100)
Proceeds from issuance of stock under employee stock plans 237 190
Net cash used in financing activities (872) (1,834)
Effect of exchange rate changes on cash, cash equivalents and restricted cash equivalent (51) 35
Net increase in cash, cash equivalents and restricted cash equivalent 8,207 26,705
Cash, cash equivalents and restricted cash equivalent, at beginning of the period 239,297 139,470
Cash, cash equivalents and restricted cash equivalent, at end of the period 247,504 166,175
Reconciliation of cash, cash equivalents, and restricted cash equivalent reported in the consolidated balance sheets    
Cash and cash equivalents 247,504 141,175
Restricted cash equivalent 0 25,000
Total cash, cash equivalents, and restricted cash equivalent shown in the consolidated statements of cash flows 247,504 166,175
Non-cash investing and financing activities    
Purchase of property and equipment included in accounts payable and accrued expenses and other current liabilities 764 1,009
Change in fair value of hedged interest rate swaps and interest rate cap 0 (2,771)
Capitalized stock-based compensation 481 13
Deferred offering costs included in accounts payable and accrued expenses and other current liabilities 0 1,288
Right-of-use assets under operating leases $ 5,670 $ 0